- Home
- JBI vs NEO Comparison
JBI vs NEO Comparison
Compare JBI & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBI | NEO |
|---|---|---|
| Founded | 2002 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 987.0M | 1.2B |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | JBI | NEO |
|---|---|---|
| Price | $5.34 | $10.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $9.17 | ★ $13.38 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.36 | $10.63 |
| Revenue Next Year | $3.16 | $9.73 |
| P/E Ratio | $12.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.26 | $4.72 |
| 52 Week High | $10.80 | $13.74 |
Technical Indicators
Market Signals| Indicator | JBI | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 74.64 |
| Support Level | $5.17 | $9.35 |
| Resistance Level | $5.66 | $10.66 |
| Average True Range (ATR) | 0.26 | 0.45 |
| MACD | 0.06 | 0.18 |
| Stochastic Oscillator | 84.21 | 95.96 |
Price Performance
Historical ComparisonAbout JBI Janus International Group Inc.
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.